IHH Healthcare

IHH

MYL5225OO007

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA Other stock markets 18:00:00 2024-05-13 EDT			5-day change	1st Jan Change
6.27 ^MYR	-0.63%		-0.63%	+3.98%

05-08	Belun Technology announced that it has received funding from IHH Healthcare Berhad	CI
04-05	IHH Healthcare Names CFO	MT

IHH Healthcare Berhad Announces Re-Designation of Mohammed Azlan Bin Hashim as Independent and Non Executive Chairman

November 27, 2018 at 12:17 am

IHH Healthcare Berhad announced re-designation of Dato' Mohammed Azlan Bin Hashim as Independent and Non Executive Chairman. The date of change is November 27, 2018.

Latest news about IHH Healthcare

Belun Technology announced that it has received funding from IHH Healthcare Berhad	05-07	CI
IHH Healthcare Names CFO	04-05	MT
IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer	04-05	CI
Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Director, Effective March 31, 2024	03-29	CI
Ihh Healthcare Berhad Appoints Yoichiro Endo as Non Independent and Non Executive Director	03-29	CI
Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Member of Nomination and Remuneration Committee	03-29	CI
Ihh Healthcare Berhad Appoints Yoichiro Endo as Non Independent and Non Executive Member of Nomination and Remuneration Committee	03-29	CI
IHH Healthcare Seeks Shareholder Approval for Buyback Program	03-28	MT
IHH Healthcare Issues New Shares Pursuant to Exercise of Options	03-24	MT
Transcript : IHH Healthcare Berhad, Q4 2023 Earnings Call, Mar 01, 2024	02-29
Ihh Healthcare Berhad Announces Final Single Tier Cash Dividend for the Financial Year Ended 31 December 2023, Payable on 26 April 2024	02-29	CI
IHH Healthcare Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
IHH Healthcare Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
IHH Healthcare Withdraws IPO Plans for Indian Lab	02-14	DJ
IHH Healthcare Indirect Unit's Subsidiary Scraps Proposed India IPO	02-14	MT
IHH Healthcare's MYR245 Million Acquisition of Bedrock Healthcare Becomes Unconditional	02-04	MT
IHH Healthcare's CFO Steps Down	02-01	MT
IHH Healthcare Berhad Announces Cessation of Joerg Ayrle as Chief Financial Officer	01-31	CI
India's big hospital chains think small to expand in booming market	12-21	RE
IHH Healthcare seeks acquisitions in Indonesia, Vietnam; eyes turnaround in China	12-01	RE
IHH Healthcare's Attributable Profit More Than Doubles in Q3	11-30	MT
Transcript : IHH Healthcare Berhad, Q3 2023 Earnings Call, Dec 01, 2023	11-30
IHH Healthcare Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-30	CI
IHH Healthcare Associate Divesting Indian Hospital for INR1.3 Billion	11-26	MT
IHH Healthcare Gets Shareholders' Nod to Commence Voluntary Liquidation of Unit	11-21	MT

IHH Healthcare Berhad is a Malaysia-based integrated healthcare provider. The Company's segments include Hospital and Healthcare, IMU Health, Labs, PLife REIT and Others. It operates its Hospital and Healthcare segment in Singapore, Malaysia, India, Greater China, Turkey and Europe and Southeast Asia. The IMU Health segment is engaged in providing educational services. The Labs segment provides diagnostic laboratory services. The PLife REIT segment is a real estate investment trust. Through its portfolio of brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway, the Company offers its patients comprehensive and personalized care ranging from primary to quaternary, and even ancillary services such as laboratory, diagnostics, imaging, and rehabilitation. It provides day-to-day healthcare services through outpatient treatment, routine check-ups, and vaccinations. Its secondary care comprises specialist consultation, local surgeries, and others.

Sector

Healthcare Facilities & Services

Calendar

2024-05-27 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for IHH Healthcare

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.27 MYR

Average target price

7.13 MYR

Spread / Average Target

+13.72%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
IHH HEALTHCARE	+3.98%	11.75B
AIER EYE HOSPITAL GROUP CO., LTD.	-18.90%	16.41B
BANGKOK DUSIT MEDICAL SERVICES	+6.31%	12.64B
APOLLO HOSPITALS ENTERPRISE LIMITED	+2.58%	10.04B
ENCOMPASS HEALTH CORPORATION	+30.17%	8.68B
RAMSAY HEALTH CARE LIMITED	-3.36%	7.68B
MOUWASAT MEDICAL SERVICES COMPANY	+7.69%	7.08B
THE ENSIGN GROUP, INC.	+5.28%	6.65B
GLOBAL HEALTH LIMITED	+47.29%	4.46B
DALLAH HEALTHCARE COMPANY	-2.21%	4.39B

Hospitals, Clinics & Primary Care Services

IHH Healthcare

Equities

IHH

MYL5225OO007

Healthcare Facilities & Services

IHH Healthcare Berhad Announces Re-Designation of Mohammed Azlan Bin Hashim as Independent and Non Executive Chairman

Latest news about IHH Healthcare

Chart IHH Healthcare

Company Profile

Income Statement Evolution

Ratings for IHH Healthcare

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Hospitals, Clinics & Primary Care Services